Non-injectable products offer a range of benefits, including - less invasive, - less costly, - a range of administration options that can suit personal preference, impaired swallow reflex capability, and/or enteral feeding, - administration on a daily basis which means lower doses and therefore reduced B12 peaks and troughs
Oral Vitamin B12: A Viable Option
Research dosages range from 10 mcg/kg to 10 mg/kg depending on the study protocol and target tissue being investigated
Apigenin, a flavonoid widely distributed in plants such as parsley, celery, and chamomile, shows the ability to inhibit CD38 142
Malabsorption disorders and IBD : Crohns, celiac, and other gastrointestinal disorders can cause damage to the intestinal lining, preventing the body from absorbing B12 and other nutrients effectively
recent guidelines affirm its use (e.g., AHA updates, StatPearls reviews)